Skip to Main Content

Author Details

Anders Johansson
Dept of Clinical Neurosciences, Karolinska Institutet
2000
33
18
PMIDPaper TitleJournal TitlePublished Year
35705502Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.Neurology2022
34198780Does Information from the Parkinson KinetiGraphâ¿¢ (PKG) Influence the Neurologist's Treatment Decisions?-An Observational Study in Routine Clinical Care of People with Parkinson's Disease.J Pers Med2021
34442364Personalized Medicine Approach in Treating Parkinson's Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice.J Pers Med2021
32198802A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia.Mov Disord2020
33543090A Pilot Study of the Feasibility and Effects of Table Tennis Training in Parkinson Disease.Arch Rehabil Res Clin Transl2020
32668433Pulse Width and Implantable Pulse Generator Longevity in Pallidal Deep Brain Stimulation for Dystonia: A Population-Based Comparative Effectiveness Study.Stereotact Funct Neurosurg2020
32613445Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's disease.J Neurol2020
32154902[Parkinson's disease - heterogeneous and complex in its clinical presentation].Lakartidningen2020
30935826Evaluation of a sensor algorithm for motor state rating in Parkinson's disease.Parkinsonism Relat Disord2019
29652438Individualization of levodopa treatment using a microtablet dispenser and ambulatory accelerometry.CNS Neurosci Ther2018
30534585Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trial.NPJ Parkinsons Dis2018
28540099Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease.Parkinsons Dis2017
27255555Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.Neurobiol Aging2016
27318707Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs.Parkinsonism Relat Disord2016
26285227Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease.IEEE J Biomed Health Inform2015
26393595Automatic Spiral Analysis for Objective Assessment of Motor Symptoms in Parkinson's Disease.Sensors (Basel)2015
26366966A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial.Clin Neuropharmacol2015
23229334Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients.AAPS J2013
23579001The HLA-DRA variation rs3129882 is not associated with Parkinson's disease in Sweden.Parkinsonism Relat Disord2013
22136163Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial.Eur J Neurol2012
22690905Interim analysis of long-term intraduodenal levodopa infusion in advanced Parkinson disease.Acta Neurol Scand2012
22360705Levodopa/carbidopa intestinal gel infusion long-term therapy in advanced Parkinson's disease.Eur J Neurol2012
22094648Complexity of motor response to different doses of duodenal levodopa infusion in Parkinson disease.Clin Neuropharmacol2012
20661024Circadian rhythmicity in levodopa pharmacokinetics in patients with Parkinson disease.Clin Neuropharmacol2010
20438759A new computer method for assessing drawing impairment in Parkinson's disease.J Neurosci Methods2010
17855149[(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results.Parkinsonism Relat Disord2008
18382177Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.Clin Neuropharmacol2008
17346749Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET.J Neurol Sci2007
15540204Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry.Proteomics2004
14534437Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis.Neuroreport2003
12488796VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis.Neuroreport2002
11176961Parkinsonism and neck extensor myopathy: a new syndrome or coincidental findings?Arch Neurol2001
10852244GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis.Neuroreport2000
  • 1 - 33 of 33

Recommended Authors

Jessika Suescun
McGovern Medical School, University of Texas Health Science Center at Houston
Career Start Year 2013
Number of shared co-authors 0
Amy W Amara
University of Colorado
Career Start Year 2011
Number of shared co-authors 0
Kalea Colletta
Hines Veterans Affairs Hospital
Career Start Year 2011
Number of shared co-authors 0
Jose-Alberto Palma
New York University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
James D Berry
Sean M Healey & AMG Center for ALS, Massachusetts General Hospital
Career Start Year 2004
Number of shared co-authors 0
Jordan J Elm
Medical University of South Carolina
Career Start Year 2002
Number of shared co-authors 0
Jennifer S Hui
Keck School of Medicine of USC
Career Start Year 2001
Number of shared co-authors 0
Hubert H Fernandez
Center for Neurological Restoration, Neurological Institute, Cleveland Clinic
Career Start Year 1998
Number of shared co-authors 0
Fenna T Phibbs
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 0
Victor W Sung
University of Alabama at Birmingham
Career Start Year 1998
Number of shared co-authors 0
Karen E Anderson
Georgetown University
Career Start Year 1996
Number of shared co-authors 0
Giselle M Petzinger
Keck School of Medicine, University of Southern California
Career Start Year 1995
Number of shared co-authors 1
Samuel M Goldman
University of California-San Francisco
Career Start Year 1994
Number of shared co-authors 0
Richard Bedlack
Duke University
Career Start Year 1992
Number of shared co-authors 0
Adam L Boxer
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1992
Number of shared co-authors 0
Bradley F Boeve
Mayo Clinic Rochester
Career Start Year 1991
Number of shared co-authors 0
Zoltan Mari
Lou Ruvo Center for Brain Health, Cleveland Clinic Nevada
Career Start Year 1991
Number of shared co-authors 0
Huw R Morris
Queen Square Institute of Neurology, University College London
Career Start Year 1991
Number of shared co-authors 1
Paul E Schulz
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year 1988
Number of shared co-authors 0
Tatsuya Yamamoto
Gladstone Institutes
Career Start Year 1987
Number of shared co-authors 0
Roger A Barker
John Van Geest Center for Brain Repair, University of Cambridge
Career Start Year 1986
Number of shared co-authors 1
Martin R Farlow
Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM)
Career Start Year 1986
Number of shared co-authors 0
Mya C Schiess
McGovern Medical School at UTHealth
Career Start Year 1982
Number of shared co-authors 0
Caroline M Tanner
UCSF School of Medicine and San Francisco VA Health Care System
Career Start Year 1980
Number of shared co-authors 0
Thomas L Davis
Vanderbilt University Medical Center
Career Start Year 1979
Number of shared co-authors 0
David G Standaert
University of Alabama at Birmingham
Career Start Year 1977
Number of shared co-authors 0
Joseph J Locascio
Harvard Medical School, Massachusetts General Hospital
Career Start Year 1975
Number of shared co-authors 0
David J Burn
Population Health Sciences Institute, Newcastle University
Career Start Year 1975
Number of shared co-authors 1
Carl H Sadowsky
Premier Research Institute and NOVA SE University
Career Start Year 1975
Number of shared co-authors 0
Mahlon R DeLong
Emory University School of Medicine
Career Start Year 1965
Number of shared co-authors 0

Collaborators

Dag Nyholm
Uppsala University
Co-authored papers 19
Nil Dizdar
Department of Biomedical and Clinical Sciences, Linkoping University
Co-authored papers 7
Olof Sydow
Karolinska Institutet
Co-authored papers 5
H??kan Widner
Skane University Hospital
Co-authored papers 4
Sven P??lhagen
Department of Neurology Karolinska University Hospital Huddinge Stockholm Sweden.
Co-authored papers 3
Jan Linder
Division of Clinical Neuroscience, Umea University
Co-authored papers 3
Rasmus Jansson-L??fmark
Unit for Pharmacokinetics and Drug Metabolism, University of Gothenburg
Co-authored papers 2
Bj??rn Holmberg
Sahlgrenska University Hospital
Co-authored papers 2
Tove Hauge
Molde Hospital HNR
Co-authored papers 2
M Wainwright
Seattle Children's Hospital, University of Washington
Co-authored papers 1
Release 1.2